Last updated on February 2018

A Clinical Trial of YMC017 in Hypertensive and Hypercholesterolemic Patients With Metabolic Syndrome


Brief description of study

This is a Randomized, open-label, 2 groups, parallel design.

Detailed Study Description

This study objective is to compare the safety and efficacy between fixed dose combination (Duowell tab) and free pill combination therapy of Telmisartan and Rosuvastatin in hypertensive and hypercholesterolemic patients with metabolic syndrome.

Clinical Study Identifier: NCT02968160

Contact Investigators or Research Sites near you

Start Over

Andrew Lee

Dongguk University Medical Center
Ilsan, Korea, Republic of
  Connect »